Seelaus Asset Management LLC Laboratory Corp Of America Holdings Transaction History

Seelaus Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$197.69 - $227.29 $98,845 - $113,645	500 Added 37.12%	1,847 $419,000
Q3 2023 Nov 16, 2023	SELL	$201.05 - $221.7 $673,517 - $742,695	-3,350 Reduced 71.32%	1,347 $270,000
Q2 2023 Jul 24, 2023	BUY	$211.93 - $241.33 $610,782 - $695,513	2,882 Added 158.79%	4,697 $1.13 Million
Q1 2023 Apr 19, 2023	BUY	$213.32 - $257.83 $387,175 - $467,961	1,815 New	1,815 $418,000
Q1 2022 Apr 13, 2022	SELL	$259.82 - $298.18 $310,744 - $356,623	-1,196 Closed	0 $0
Q4 2021 Jan 10, 2022	SELL	$271.6 - $314.21 $241,724 - $279,646	-890 Reduced 42.67%	1,196 $376,000
Q2 2021 Jul 27, 2021	SELL	$251.87 - $278.14 $326,171 - $360,191	-1,295 Reduced 38.3%	2,086 $575,000
Q1 2021 Apr 26, 2021	SELL	$204.88 - $255.03 $21,512 - $26,778	-105 Reduced 3.01%	3,381 $862,000
Q4 2020 Feb 08, 2021	BUY	$186.91 - $214.42 $651,568 - $747,468	3,486 New	3,486 $710,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Seelaus Asset Management LLC with notifications on news.